Company: INDP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023333
Chunk: 28

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 28
---
 condensed consolidated financial statements included in this
Quarterly Report.

We
did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under the SEC
rules.

Critical
Accounting Policies

This
discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial
statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial
statements requires us to make estimates that affect the reported amounts of our assets, liabilities and expenses. Significant accounting
policies employed, including the use of estimates, are presented in the notes to our annual financial statements included in our 2024
Annual Report on Form 10-K. We periodically evaluate our estimates, which are based on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances. Critical accounting policies are those that are most important to the portrayal
of our financial condition and results of operations and require our subjective or complex judgments, resulting in the need to make estimates
about the effect of matters that are inherently uncertain. If actual performance should differ from historical experience or if the underlying
assumptions were to change, our financial condition and results of operations may be materially impacted.

Our
critical accounting policies are described under the heading “Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Critical Accounting Policies” in our 2024 Annual Report on Form 10-K. During the six months ended
June 30, 2025, there were no material changes to our critical accounting policies from those discussed in our 2024 Annual Report on Form
10-K.

Recently
Issued Accounting Pronouncements

Certain recently issued accounting pronouncements are discussed in Note 2 to our unaudited condensed consolidated financial statements
included in this Quarterly Report.

Item
3. Quantitative and Qualitative Disclosures about Market Risk

We
are a smaller reporting company as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
and are not required to provide the information otherwise required under this Item 3.

Item
4. Controls and Procedures

Limitations
on Effectiveness of Controls and Procedures

In
designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how
well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the